Beijing Science Sun Pharmaceutical Co Ltd (300485) — Capital Reinvestment Ratio
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Capital Reinvestment Ratio of 0.54x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.68 Million) in capital expenditures (CN¥15.52 Million). See 300485 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Science Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Beijing Science Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods. Check Beijing Science Sun Pharmaceutical Co Lt cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see how much is Beijing Science Sun Pharmaceutical Co Lt worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | CN¥135.97 Million | CN¥101.13 Million | ▼ -70.2% |
| 2023 | 2.49x | CN¥21.21 Million | CN¥52.91 Million | ▲ +536.5% |
| 2022 | 0.39x | CN¥110.43 Million | CN¥43.28 Million | ▲ +56.5% |
| 2021 | 0.25x | CN¥183.30 Million | CN¥45.91 Million | ▼ -43.9% |
| 2020 | 0.45x | CN¥263.73 Million | CN¥117.84 Million | ▼ -30.8% |
| 2019 | 0.65x | CN¥172.52 Million | CN¥111.42 Million | ▼ -52.2% |
| 2018 | 1.35x | CN¥146.52 Million | CN¥198.00 Million | ▲ +3.5% |
| 2017 | 1.31x | CN¥108.21 Million | CN¥141.25 Million | ▲ +89.0% |
| 2016 | 0.69x | CN¥212.89 Million | CN¥147.00 Million | ▲ +269.4% |
| 2015 | 0.19x | CN¥169.36 Million | CN¥31.65 Million | ▲ +342.6% |
| 2014 | 0.04x | CN¥214.23 Million | CN¥9.05 Million | ▼ -57.2% |
| 2013 | 0.10x | CN¥196.82 Million | CN¥19.42 Million | ▼ -81.4% |
| 2012 | 0.53x | CN¥151.93 Million | CN¥80.76 Million | ▲ +50.1% |
| 2011 | 0.35x | CN¥77.06 Million | CN¥27.29 Million | — |